Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Lowder, James"'
Autor:
Savona, Michael R, Odenike, Olatoyosi, Amrein, Philip C, Steensma, David P, DeZern, Amy E, Michaelis, Laura C, Faderl, Stefan, Harb, Wael, Kantarjian, Hagop, Lowder, James, Oganesian, Aram, Azab, Mohammad, Garcia-Manero, Guillermo
Publikováno v:
In The Lancet Haematology April 2019 6(4):e194-e203
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Issa, Jean-Pierre J, Roboz, Gail, Rizzieri, David, Jabbour, Elias, Stock, Wendy, O'Connell, Casey, Yee, Karen, Tibes, Raoul, Griffiths, Elizabeth A, Walsh, Katherine, Daver, Naval, Chung, Woonbok, Naim, Sue, Taverna, Pietro, Oganesian, Aram, Hao, Yong, Lowder, James N, Azab, Mohammad, Kantarjian, Hagop
Publikováno v:
In The Lancet Oncology September 2015 16(9):1099-1110
Publikováno v:
In Clinical Gastroenterology and Hepatology 2008 6(9):999-1003
Autor:
Roboz, Gail J., Kantarjian, Hagop M., Yee, Karen W. L., Kropf, Patricia L., O'Connell, Casey L., Griffiths, Elizabeth A., Stock, Wendy, Daver, Naval G., Jabbour, Elias, Ritchie, Ellen K., Walsh, Katherine J., Rizzieri, David, Lunin, Scott D., Curio, Tania, Chung, Woonbok, Hao, Yong, Lowder, James N., Azab, Mohammad, Issa, Jean‐Pierre J.
Publikováno v:
Cancer
BACKGROUND Outcomes for patients with relapsed or refractory acute myeloid leukemia (AML) are poor. Guadecitabine, a next‐generation hypomethylating agent, could be useful in treating such patients. METHODS In this multicenter, open‐label, phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::335719cfa37322c15d93c38ac0921079
http://europepmc.org/articles/PMC5814873
http://europepmc.org/articles/PMC5814873
Autor:
Xu, Cong, Goggin, Timothy K., Su, Xiang‐Yao, Taverna, Pietro, Oganesian, Aram, Lowder, James N., Azab, Mohammad, Kantarjian, Hagop
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Guadecitabine (SGI‐110) is a novel next‐generation hypomethylating agent (HMA) administered as s.c. injection with extended decitabine exposure. Dose/exposure‐response analyses of longitudinal measures of long interspersed nucleotide element‐
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0349a8cf00c9a03c7a527b265ba40fd2
http://europepmc.org/articles/PMC5658282
http://europepmc.org/articles/PMC5658282
Autor:
Carpenter, Paul A., Lowder, James, Johnston, Laura, Frangoul, Haydar, Khoury, Hanna, Parker, Pablo, Jerome, Keith R., McCune, Jeannine S., Storer, Barry, Martin, Paul, Appelbaum, Frederick, Abonour, Rafat, Westervelt, Peter, Anasetti, Claudio
Publikováno v:
In Biology of Blood and Marrow Transplantation 2005 11(6):465-471
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Crabb, Simon, Danson, Sarah, Catto, James, McDowell, Cathy, Lowder, James, Caddy, Joshua, Dunkley, Denise, Rajaram, Jessica, Ellis, Deborah, Hill, Stephanie, Hathorn, David, Whitehead, Amy, Mihalis Kalevras, Huddart, Robert, Griffiths, Gareth
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT): a checklist for a set of scientific, ethical and administrative elements recommended to be listed in a protocol [31]. (PDF 58 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d7669d632ec3ce1f0a579adbea7ce9
Autor:
Crabb, Simon, Danson, Sarah, Catto, James, McDowell, Cathy, Lowder, James, Caddy, Joshua, Dunkley, Denise, Rajaram, Jessica, Ellis, Deborah, Hill, Stephanie, Hathorn, David, Whitehead, Amy, Mihalis Kalevras, Huddart, Robert, Griffiths, Gareth
Dose modification of SGI-110, gemcitabine and cisplatin guidance. This guidance is used if the patient does not meet certain haematological parameters or non-haematological toxicities have occurred. (PDF 107 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c92f01549142e47a1ad9eca43e15422